Delivery pivotal as UK life sciences plan takes shape
Life Sciences Council meeting hosted by chancellor Jeremy Hunt has unfolded in Downing Street
Read Moreby John Pinching | May 26, 2023 | News | 0
Life Sciences Council meeting hosted by chancellor Jeremy Hunt has unfolded in Downing Street
Read Moreby John Pinching | Jan 30, 2023 | News | 0
Lilly is calling for Government to freeze the statutory scheme repayment rate for 2023
Read Moreby John Pinching | Jan 16, 2023 | News | 0
Major industry names depart leaving UK pricing deal in serious jeopardy
Read Moreby John Pinching | Jan 9, 2023 | News | 0
New financial assistance emerges as UK Government announces imminent discharge fund
Read Moreby John Pinching | Oct 10, 2022 | News | 0
Partnership will evaluate AI-powered technology in lung cancer care
Read Moreby John Pinching | Aug 19, 2022 | News | 0
Senior public health figures take unusual step of warning government about energy costs
Read Moreby John Pinching | Mar 17, 2022 | News | 0
The NHS has not met the 18-week target for people to receive planned treatment in England since February 2016
Read Moreby John Pinching | Mar 4, 2022 | News | 0
New detailed datasets will more accurately map out the impact of obesity throughout UK
Read Moreby Anna Smith | Mar 27, 2020 | News | 0
Thermo Fisher has also announced that it has received the CE mark in the European Union for its diagnostic test.
Read Moreby Anna Smith | Jan 17, 2020 | News | 0
The plans were “ambitions”, and primary care is not being given the time, support and funding it needs.
Read Moreby Selina McKee | Sep 24, 2019 | News | 0
Under the plans, people already living in the EU who have their healthcare funded by the UK will have their healthcare costs covered for six months
Read Moreby Anna Smith | Sep 5, 2019 | News | 0
The NHS will recieve a cash increase of £33.9 billion a year by 2023-24 compared to 2018-19 budgets.
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479